PharmaCyte Biotech Inc (PMCB)

[Uboat]

Something is going to happen with Celgene IMO---- if it has not happened already.


http://pharmacyte.com/nuvilex-eyes-fda-fast-track-abraxane-approved-pancreatic-cancer/

American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders, Celgene Corporation (NASDAQ: CELG) Chief Executive Officer, Mark J. Alles had recently highlighted the company's pipeline opportunities and various partnerships which the company could significantly expand its Abraxane franchise for solid tumor cancers, directing to several lung cancer trials in combination with new immune-oncology drugs. Alles believes Abraxane could eventually help cure certain subsets of early-stage pancreatic cancer. Abraxane is a prescription medicine used to treat advanced pancreatic cancer, when used in combination with gemcitabine, as the first medicine patients receive for advanced pancreatic cancer. Abraxane is a chemotherapy, which helps patients control or slow the spread of cancer cells.